BDBM714779 4-((5-(2-chloro-3-hydroxy-5- (trifluoromethyl)phenyl)-1,3,4- thiadiazol-2-yl)methyl)-6-(2,2,2- trifluoroethyl)-4,6- diazaspiro[2.4]heptane-5,7-dione::US20250026745, Compound I-40

SMILES O=C1N(CC(F)(F)F)C(=O)C2(CC2)N1Cc1nnc(-c2cc(C(F)(F)F)cc(O)c2Cl)s1

InChI Key InChIKey=XKYMYRQLDJIMTG-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 714779   

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Bluejay Therapeutics

US Patent
LigandPNGBDBM714779(4-((5-(2-chloro-3-hydroxy-5- (trifluoromethyl)phen...)
Affinity DataIC50: 9.80nMAssay Description:More specifically, recombinant 17β-HSD13 protein was assayed in a buffer containing 200 mM Tris pH 7.5, 0.01% Triton X-100, and 0.02% BSA into a 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent